Approaching the active conformation of 1,3-diaminopyrimidine based covalent inhibitors of Bruton's tyrosine kinase for treatment of Rheumatoid arthritis

被引:13
作者
Huang, Zhenhua [1 ]
Zhang, Qian [1 ]
Yan, Lianzhong [1 ]
Zhong, Guizhen [1 ]
Zhang, Linqi [1 ]
Tan, Xiaojuan [1 ]
Wang, Yanli [1 ]
机构
[1] KBP Biosci, C201,750 Shunhua Rd, Jinan 250101, Shandong, Peoples R China
关键词
Bruton's tyrosine kinase (BTK); Rheumatoid arthritis (RA); Collagen-induced arthritis (CIA); 1,3-Diamino-pyrimidine; BINDING; BTK; DISCOVERY;
D O I
10.1016/j.bmcl.2016.03.011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
By applying conformational restrictions, we were able to discover highly potent 1,3-diaminopyrimidine based covalent inhibitors of BTK, such as 8a (IC50 = 3.76 nM), and providing useful information of its active conformation. We are developing these novel small molecule covalent inhibitors of BTK toward oral agents for Rheumatoid arthritis. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1954 / 1957
页数:4
相关论文
共 11 条
[1]   Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks [J].
Barf, Tjeerd ;
Kaptein, Allard .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (14) :6243-6262
[2]   Bruton's Tyrosine Kinase (BTK) Inhibitors in Clinical Trials [J].
Burger, Jan A. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (01) :44-49
[3]   Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans [J].
Evans, Erica K. ;
Tester, Richland ;
Aslanian, Sharon ;
Karp, Russell ;
Sheets, Michael ;
Labenski, Matthew T. ;
Witowski, Steven R. ;
Lounsbury, Heather ;
Chaturvedi, Prasoon ;
Mazdiyasni, Hormoz ;
Zhu, Zhendong ;
Nacht, Mariana ;
Freed, Martin I. ;
Petter, Russell C. ;
Dubrovskiy, Alex ;
Singh, Juswinder ;
Westlin, William F. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 346 (02) :219-228
[4]   Targeting Bruton's tyrosine kinase in B cell malignancies [J].
Hendriks, Rudi W. ;
Yuvaraj, Saravanan ;
Kil, Laurens P. .
NATURE REVIEWS CANCER, 2014, 14 (04) :219-232
[5]   In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors [J].
Konsoula, Roula ;
Jung, Mira .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 361 (1-2) :19-25
[6]   Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis [J].
Lou, Yan ;
Han, Xiaochun ;
Kuglstatter, Andreas ;
Kondru, Rama K. ;
Sweeney, Zachary K. ;
Soth, Michael ;
McIntosh, Joel ;
Litman, Renee ;
Suh, Judy ;
Kocer, Buelent ;
Davis, Dana ;
Park, Jaehyeon ;
Frauchiger, Sandra ;
Dewdney, Nolan ;
Zecic, Hasim ;
Taygerly, Joshua P. ;
Sarma, Keshab ;
Hong, Junbae ;
Hill, Ronald J. ;
Gabriel, Tobias ;
Goldstein, David M. ;
Owens, Timothy D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) :512-516
[7]   Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase [J].
Pan, Zhengying ;
Scheerens, Heleen ;
Li, Shyr-Jiann ;
Schultz, Brian E. ;
Sprengeler, Paul A. ;
Burrill, L. Chuck ;
Mendonca, Rohan V. ;
Sweeney, Michael D. ;
Scott, Keana C. K. ;
Grothaus, Paul G. ;
Jeffery, Douglas A. ;
Spoerke, Jill M. ;
Honigberg, Lee A. ;
Young, Peter R. ;
Dalrymple, Stacie A. ;
Palmer, James T. .
CHEMMEDCHEM, 2007, 2 (01) :58-61
[8]   Binding properties of aromatic carbon-bound fluorine [J].
Razgulin, Andrew V. ;
Mecozzi, Sandro .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) :7902-7906
[9]   Beyond Picomolar Affinities: Quantitative Aspects of Noncovalent and Covalent Binding of Drugs to Proteins [J].
Smith, Adam J. T. ;
Zhang, Xiyun ;
Leach, Andrew G. ;
Houk, K. N. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :225-233
[10]   Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase [J].
Smith, Christopher R. ;
Dougan, Douglas R. ;
Komandla, Mallareddy ;
Kanouni, Toufike ;
Knight, Beverly ;
Lawson, J. David ;
Sabat, Mark ;
Taylor, Ewan R. ;
Phong Vu ;
Wyrick, Corey .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) :5437-5444